Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphoma

Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphoma

Majority of non-Hodgkin lymphoma (NHL) patients who achieve partial response (PR) or stable disease (SD) to CAR T-cell therapy (CAR T) on day +30 progress and only 30% achieve spontaneous complete response (CR). This study is the first to evaluate the role of consolidative radiotherapy (cRT) for re...

Full description

Bibliographic Details
Main Authors: Omran Saifi, William G Breen, Scott C Lester, William G Rule, Bradley J Stish, Allison Rosenthal, Javier Munoz, Yi Lin, Radhika Bansal, Matthew A Hathcock, Patrick B Johnston, Stephen M Ansell, Jonas Paludo, Arushi Khurana, Jose C Villasboas, Yucai Wang, Madiha Iqbal, Muhamad Alhaj Moustafa, Hemant S Murthy, Mohamed A. Kharfan-Dabaja, Jennifer L Peterson, Bradford S Hoppe
Format: Article
Language:English
Published: Ferrata Storti Foundation 2023-06-01
Series:Haematologica
Online Access:https://haematologica.org/article/view/11115

Internet

https://haematologica.org/article/view/11115

Similar Items